Transcatheter Embolization and Occlusion Devices Market, By Product (Coil and Non Coil), By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4346
|
Published Date
October 2025
|
Pages
303
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Transcatheter Embolization and Occlusion Devices Market size was valued at US$ 5,493.20 Million in 2024, expanding at a CAGR of 7.80% from 2025 to 2032.
Transcatheter embolization and occlusion devices facilitate the delivery of synthetic embolic materials into the body through a catheter inserted into a targeted blood vessel or anatomical site. This minimally invasive procedure, commonly performed in interventional radiology, is used to block blood flow to cancerous tumors, effectively starving them of nutrients and oxygen. In some cases, synthetic materials are coated with chemotherapeutic agents to enable a dual action—simultaneously obstructing the tumor’s blood supply while delivering targeted cytotoxic therapy. This combined approach enhances treatment efficacy by maximizing tumor targeting and minimizing systemic side effects.
Globally, governments are actively supporting the adoption and development of these advanced interventional techniques. For instance, the U.S. Food and Drug Administration (FDA) has approved numerous embolization devices, fostering innovation and clinical adoption. The European Union, through its Horizon Europe program, has allocated substantial funding towards research in minimally invasive oncology treatments, including transcatheter embolization. Additionally, increasing cancer incidence worldwide—projected by the World Health Organization (WHO) to reach 28.4 million new cases annually by 2040—is driving government initiatives to improve cancer treatment infrastructure and access to advanced therapies such as embolization, fueling market growth and innovation.
Transcatheter Embolization and Occlusion Devices Market- Market Dynamics
Rising Demand for Minimally Invasive Techniques Drives Market Growth
The increasing demand for minimally invasive techniques is expected to significantly drive the growth of the transcatheter embolization and occlusion device market in the near future. Minimally invasive surgeries involve the use of small incisions or natural body openings to access and treat internal organs, tissues, or structures, thereby minimizing trauma to the patient’s body. Transcatheter embolization and occlusion devices are integral to these procedures, offering benefits such as reduced invasiveness, shorter recovery times, targeted treatment delivery, decreased pain, lower risk of complications, and the potential for outpatient care.
For example, Intuitive Surgical Inc., a U.S.-based leader in minimally invasive medical technologies, reported approximately 1,875,000 surgical procedures performed with its da Vinci surgical systems in 2022—an 18% increase from about 1,594,000 procedures in 2021. This rising adoption of minimally invasive approaches underscores the growing market demand for advanced embolization and occlusion devices, positioning them as key drivers in improving patient outcomes and healthcare efficiency.
Transcatheter Embolisation and Occlusion Devices Market- Segmentation Analysis:
The Global Transcatheter Embolisation and Occlusion Devices Market is segmented on the basis of Product and Region.
The transcatheter embolization and occlusion devices market is segmented into two primary product categories: Coil and Non-Coil devices. The non-coil segment is expected to dominate the market in 2025, capturing the highest revenue share due to its broad versatility and superior effectiveness across various clinical applications. Non-coil devices, which include liquid embolic agents and particle embolization products, offer precise and controlled embolization, making them particularly suitable for treating complex vascular conditions. Their ability to navigate challenging anatomical structures with minimal complications has led to widespread adoption by interventional radiologists and surgeons. According to the U.S. Food and Drug Administration (FDA), advancements in non-coil embolization materials have significantly improved patient outcomes by reducing procedure times and enhancing safety profiles, further driving their market dominance.
Transcatheter Embolization and Occlusion Devices Market- Geographical Insights
Geographically, the North American market for transcatheter embolization and occlusion devices is projected to lead globally in 2025. This growth is primarily fueled by the rising adoption of interventional radiology (IR) procedures across the region. Procedures like Uterine Fibroid Embolization (UFE), a minimally invasive technique for treating symptomatic uterine fibroids, are becoming increasingly popular due to their ability to offer faster recovery times and avoid major surgeries such as hysterectomy. The American College of Radiology (ACR) reports a consistent annual increase in IR procedures, reflecting growing patient preference for less invasive treatment options and heightened awareness among healthcare providers. In addition to UFE, embolization devices are widely utilized in managing conditions like atrial fibrillation and varicose veins, which collectively contribute to expanding market demand.
The Asia Pacific region is expected to register the fastest growth rate in the transcatheter embolization and occlusion device market between 2025 and 2032. This surge is largely driven by the increasing prevalence of cancer within the region. Embolization plays a crucial role in the management of various tumors, including liver and lung cancers, offering targeted treatment options that improve patient prognosis. According to the World Health Organization (WHO), cancer incidence in Asia Pacific is projected to rise by more than 50% over the next decade, underscoring the urgent need for advanced therapeutic interventions. Concurrently, increased government healthcare investments and improvements in medical infrastructure are expanding access to cutting-edge technologies, which further propels market growth. Countries such as China and India are leading initiatives to enhance oncology care, making the Asia Pacific a key driver of innovation and adoption in the embolization device sector.
Transcatheter Embolization and Occlusion Devices Market- Competitive Landscape:
The Transcatheter Embolization and Occlusion Devices market is highly competitive, led by industry giants such as Abbott, Boston Scientific Corporation, Terumo Corporation, Medtronic, and DePuy Synthes (a Johnson & Johnson company). These market leaders offer a broad portfolio of innovative devices, including embolization coils, vascular plugs, and liquid embolic agents, often integrated with advanced imaging technologies and catheter navigation systems. Competition is primarily driven by technological advancements, device miniaturization, and improvements in safety and efficacy across applications in oncology, neurology, and peripheral vascular procedures.
Recent Developments:
- In January 2025, Stryker announced the acquisition of Inari Medical for USD 4.9 billion, strengthening its position in the venous thromboembolism treatment segment.
- In July 2025, Teleflex completed the acquisition of BIOTRONIK’s vascular intervention business for EUR 760 million, broadening its product portfolio to include drug-coated balloons and the Freesolve resorbable scaffold.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott
- Boston Scientific Corporation
- Terumo Corporation
- Medtronic
- DePuy Synthes (Johnson & Johnson)
- Stryker
- Cordis
- Pfizer Inc.
- Sirtex SIR-Spheres Pty Ltd.
- Nordion (Canada) Inc.
- Others
GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Coil
- Pushable Coils
- Detachable Coils
- Non Coil
- Flow Diverting Devices
- Embolization Particles
- Liquid Embolics
- Other Embolization and Occlusion Devices
- Accessories
GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Transcatheter Embolization And Occlusion Devices Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Transcatheter Embolization And Occlusion Devices Market Snippet by Product
2.1.2. Transcatheter Embolization And Occlusion Devices Market Snippet by Country
2.1.3. Transcatheter Embolization And Occlusion Devices Market Snippet by Region
2.2. Competitive Insights
3. Transcatheter Embolization And Occlusion Devices Key Market Trends
3.1. Transcatheter Embolization And Occlusion Devices Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Transcatheter Embolization And Occlusion Devices Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Transcatheter Embolization And Occlusion Devices Market Opportunities
3.4. Transcatheter Embolization And Occlusion Devices Market Future Trends
4. Transcatheter Embolization And Occlusion Devices Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Transcatheter Embolization And Occlusion Devices Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Transcatheter Embolization And Occlusion Devices Market Landscape
6.1. Transcatheter Embolization And Occlusion Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Transcatheter Embolization And Occlusion Devices Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Coil
7.1.2.1. Pushable Coils
7.1.2.2. Detachable Coils
7.1.3. Non Coil
7.1.3.1. Flow Diverting Devices
7.1.3.2. Embolization Particles
7.1.3.3. Liquid Embolics
7.1.3.4. Other Embolization and Occlusion Devices
7.1.3.5. Accessories
8. Transcatheter Embolization And Occlusion Devices Market– By Geography
8.1. Introduction
8.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
8.2. North America
8.2.1. Overview
8.2.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in North America
8.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.2.5. U.S.
8.2.5.1. Overview
8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.2.5.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.2.6. Canada
8.2.6.1. Overview
8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.2.6.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Europe
8.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.5. Germany
8.3.5.1. Overview
8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.5.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.6. UK
8.3.6.1. Overview
8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.6.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.7. France
8.3.7.1. Overview
8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.7.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.8. Italy
8.3.8.1. Overview
8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.9. Spain
8.3.9.1. Overview
8.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.9.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.10. The Netherlands
8.3.10.1. Overview
8.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.10.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.11. Sweden
8.3.11.1. Overview
8.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.11.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.12. Russia
8.3.12.1. Overview
8.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.12.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.13. Poland
8.3.13.1. Overview
8.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.13.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.3.14. Rest of Europe
8.3.14.1. Overview
8.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Asia Pacific
8.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.5. China
8.4.5.1. Overview
8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.5.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.6. India
8.4.6.1. Overview
8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.7. Japan
8.4.7.1. Overview
8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.7.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.8. South Korea
8.4.8.1. Overview
8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.8.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.9. Australia
8.4.9.1. Overview
8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.9.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.10. Indonesia
8.4.10.1. Overview
8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.10.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.11. Thailand
8.4.11.1. Overview
8.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.12. Philippines
8.4.12.1. Overview
8.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.12.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.4.13. Rest of APAC
8.4.13.1. Overview
8.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.13.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5. Latin America (LATAM)
8.5.1. Overview
8.5.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Latin America
8.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5.5. Brazil
8.5.5.1. Overview
8.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.5.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5.6. Mexico
8.5.6.1. Overview
8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.6.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5.7. Argentina
8.5.7.1. Overview
8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.7.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5.8. Colombia
8.5.8.1. Overview
8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.8.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.5.9. Rest of LATAM
8.5.9.1. Overview
8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.9.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6. Middle East and Africa (MEA)
8.6.1. Overview
8.6.2. Transcatheter Embolization And Occlusion Devices Key Manufacturers in Middle East and Africa
8.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.5. Saudi Arabia
8.6.5.1. Overview
8.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.5.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.6. UAE
8.6.6.1. Overview
8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.6.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.7. Israel
8.6.7.1. Overview
8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.7.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.8. Turkey
8.6.8.1. Overview
8.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.8.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.9. Algeria
8.6.9.1. Overview
8.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.9.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.10. Egypt
8.6.10.1. Overview
8.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.10.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
8.6.11. Rest of MEA
8.6.11.1. Overview
8.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.11.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
9. Key Vendor Analysis- Transcatheter Embolization And Occlusion Devices Industry
9.1. Competitive Benchmarking
9.1.1. Competitive Dashboard
9.1.2. Competitive Positioning
9.2. Company Profiles
9.2.1. Abbott
9.2.2. Boston Scientific Corporation
9.2.3. Terumo Corporation
9.2.4. Medtronic
9.2.5. DePuy Synthes (Johnson & Johnson)
9.2.6. Stryker
9.2.7. Cordis
9.2.8. Pfizer Inc.
9.2.9. Sirtex SIR-Spheres Pty Ltd.
9.2.10. Nordion (Canada) Inc.
9.2.11. Others
10. 360 Degree AnalystView
11. Appendix
11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
